Orchid Pharma Fact Sheet, Orchid Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Pharma Fact Sheet    (ORCHID)


FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth


Here is the latest financial fact sheet of Orchid Pharma. For more details, see the Orchid Pharma quarterly results and Orchid Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA Price History

Price Rs 1,575.7
Mkt Cap Rs m 140,181
Vol '000 2.1
P/E X -128.6
P/CF X -45.5
EPS (TTM) Rs -12.2
% ch % -1.1
No. of shares m 88.96
% ch week % -7.2
% ch 1-mth % -35.9
% ch 12-mth % -
52 week H/L Rs 2,680.0/18.0
(As on May 7, 2021 01:51:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA Financials

No. of Mths
Year Ending
12
Mar-09
*
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
18
Sep-13
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA EQUITY SHARE DATA
High Rs330239344325194 
Low Rs577512811235 
Sales per share (Unadj.) Rs184.1190.7253.0266.0276.5 
Earnings per share (Unadj.) Rs-7.048.222.213.8-79.2 
Diluted earnings per shareRs-5.538.117.611.0-62.7 
Cash flow per share (Unadj.) Rs12.170.241.135.7-43.5 
Dividends per share (Unadj.) Rs1.0010.003.003.000 
Adj. dividends per shareRs0.797.922.382.380.00 
Dividend yield (eoy) %0.56.41.31.40 
Book value per share (Unadj.) Rs90.0133.1151.8160.753.9 
Adj. book value per shareRs71.2105.4120.2127.342.7 
Shares outstanding (eoy) m70.4470.4470.4470.4470.45 
Bonus/Rights/Conversions  WC---ESOP 
Price / Sales ratio x1.10.80.90.80.4 
Avg P/E ratio x-27.83.310.615.8-1.4 
P/CF ratio (eoy) x16.02.25.76.1-2.6 
Price / Book Value ratio x2.21.21.61.42.1 
Dividend payout %-14.420.813.521.70 
Avg Mkt Cap Rs m13,63011,05916,62415,3918,067 
No. of employees `0004.03.7NA4.52.8 
Total wages/salary Rs m1,4091,7751,7371,7642,527 
Avg. sales/employee Rs Th3,210.03,630.9NM4,205.66,956.1 
Avg. wages/employee Rs Th348.7479.8NM396.0902.5 
Avg. net profit/employee Rs Th-121.3916.9NM218.8-1,993.0 
ORCHID PHARMA INCOME DATA
Net Sales Rs m12,96913,43517,81818,73619,477 
Other income Rs m86186447562407 
Total revenues Rs m13,82913,52018,26519,29819,884 
Gross profit Rs m1,706-1,5693,5643,5661,103 
Depreciation Rs m1,3401,5491,3351,5372,519 
Interest Rs m1,5652,4231,1681,7985,227 
Profit before tax Rs m-338-5,4551,509793-6,236 
Minority Interest Rs m000020 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m010,153207-39511 
Tax Rs m1521,306154-220-125 
Profit after tax Rs m-4903,3931,562975-5,580 
Gross profit margin %13.2-11.720.019.05.7 
Effective tax rate %-44.9-23.910.2-27.82.0 
Net profit margin %-3.825.38.85.2-28.7 
ORCHID PHARMA BALANCE SHEET DATA
Current assets Rs m15,95417,00515,26312,53311,014 
Current liabilities Rs m8,55810,85219,89415,51132,060 
Net working cap to sales %57.045.8-26.0-15.9-108.1 
Current ratio x1.91.60.80.80.3 
Inventory Days Days21611512713095 
Debtors Days Days1892001052234 
Net fixed assets Rs m25,54220,72220,74124,26129,440 
Share capital Rs m704704704704705 
"Free" reserves Rs m5,4798,4548,1069,3102,043 
Net worth Rs m6,3389,37710,69211,3233,800 
Long term debt Rs m26,15915,3036,04110,7429,018 
Total assets Rs m43,91639,90639,10239,38146,510 
Interest coverage x0.8-1.32.31.4-0.2 
Debt to equity ratio x4.11.60.60.92.4 
Sales to assets ratio x0.30.30.50.50.4 
Return on assets %2.414.67.07.0-0.8 
Return on equity %-7.736.214.68.6-146.9 
Return on capital %3.828.917.211.6-3.7 
Exports to sales %71.972.740.745.237.9 
Imports to sales %32.728.232.437.822.6 
Exports (fob) Rs m9,3209,7627,2598,4677,378 
Imports (cif) Rs m4,2343,7875,7737,0894,406 
Fx inflow Rs m9,59210,0527,8688,9287,513 
Fx outflow Rs m5,0065,2676,6588,2195,649 
Net fx Rs m4,5864,7851,2107091,865 
ORCHID PHARMA CASH FLOW
From Operations Rs m 459 -343 3,321 7,370 1,682 
From Investments Rs m -4,770 14,128 -3,674 -2,931 -9,860 
From Financial Activity Rs m 4,311 -10,768 -778 -4,802 6,644 
Net Cashflow Rs m 0 3,016 -1,130 -362 -1,535 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 32.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.6%
FIIs 3.3%
ADR/GDR 4.6%
Free float 55.3%
Shareholders 84,811
Pledged promoter(s) holding 54.9%
 

Company Information

REGD OFF Orchid Towers, 313, Valluvar Kottam Road, Nungambakkam, Chennai-34
E-MAIL corporate@orchidpharma.com WEB www.orchidpharma.com
TELEPHONE (044) 2821 1000 FAX (044) 2827 5960
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Integrated Enterp., II Flr., Kences Tower, North Usman Rd., Chennai-17
AUDITOR SNB Associates
CHM: K. Raghavendra Rao (MD) COMP SEC: L. Chandrasekar YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ALKEM LABORATORIES  AJANTA PHARMA  STRIDES PHARMA SCIENCE  CIPLA  WYETH  

Compare ORCHID PHARMA With:   ALKEM LABORATORIES  AJANTA PHARMA  STRIDES PHARMA SCIENCE  CIPLA  WYETH  

Compare ORCHID PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Trades Marginally Higher, Dow Futures Up by 22 Points(12:30 pm)

Share markets in India are presently trading marginally higher. The BSE Sensex is trading up by 180 points, up 0.4% at 49,129 levels.

Views on news

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA 8-QTR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS